I
Instadose Pharma Corp
OTC:INSD
Instadose Pharma Corp
OTC:INSD
Price:
0.0001
USD
Market Closed
Market Cap:
$531.9
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Instadose Pharma Corp
OTC:INSD
|
US |
|
Ascentech KK
TSE:3565
|
JP |
|
Monex Group Inc
TSE:8698
|
JP |
|
Satyamitra Kemas Lestari Tbk PT
IDX:SMKL
|
ID |
|
Omaxe Ltd
NSE:OMAXE
|
IN |
|
ABM Industries Inc
NYSE:ABM
|
US |
|
Y
|
Yubico AB
STO:YUBICO
|
SE |
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
|
P
|
Pentamaster Corporation Bhd
KLSE:PENTA
|
MY |
|
Sastasundar Ventures Ltd
NSE:SASTASUNDR
|
IN |
|
U
|
UMediC Group Bhd
KLSE:UMC
|
MY |
|
K
|
Kmc Properties ASA
OSE:KMCP
|
NO |
Income Statement
Earnings Waterfall
Instadose Pharma Corp
Instadose Pharma Corp
Income Statement
Instadose Pharma Corp
Instadose Pharma Corp
Currency: USD
| Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Operating Income |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-241%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-247%
|
|
| Net Income | |||||||
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-13%
|
(0)
-149%
|
(0)
-67%
|
(0)
-282%
|
(2)
-247%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
